For Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN), Fintel provides a proprietary Short Squeeze Score designed to identify companies with the highest risk of experiencing a short squeeze. This score is derived from a multi-factor quantitative model that incorporates metrics such as short interest, float, and short borrow fee rates.1
While the exact real-time Short Squeeze Score for SONN typically requires a Fintel subscription to view, we can examine the underlying components that contribute to it:
- Short Interest: As of the latest data, the reported short interest for SONN stands at 1,144,899 shares.1
- Short Interest Ratio (Days to Cover): This metric indicates how many days it would take for short sellers to cover their positions, given the average daily trading volume. For SONN, it is currently 2.05 Days to Cover.1
- Short Interest % Float: This percentage represents the proportion of the company's publicly available shares that are currently sold short. SONN's Short Interest % Float is 18.38%.1
- Off-Exchange Short Volume Ratio: This shows the percentage of total short volume executed off-exchange (including dark pools). For SONN, this ratio is 46.75%.1
A higher Short Squeeze Score (with 50 being the average) suggests a greater potential for a short squeeze relative to its peers.1 Investors often monitor these metrics, alongside short borrow fee rates and short shares availability, to gauge the pressure on short sellers.
For a detailed, real-time Short Squeeze Score and to explore the historical trends of these metrics, you can visit the Fintel page for SONN's Short Squeeze data.
